Yoshihito Nagura

发表

Development of hepatocellular carcinoma from various phases of chronic hepatitis B virus infection

K. Matsuura, Etsuko Iio, Yasuhito Tanaka, 2021, PloS one.

A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C

A. Tamori, K. Matsuura, Y. Takei, 2021, PloS one.

Percutaneous Transhepatic Self-expanding Metallic Stent Placement for the Treatment of Malignant Afferent Loop Obstruction

T. Joh, K. Fujioka, Naruomi Jinno, 2017, Internal medicine.

Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis B

K. Matsuura, Koji Fujita, Takeshi Matsui, 2021, PloS one.

Primary Sclerosing Cholangitis and Autoimmune Hepatitis Overlapping Syndrome Complicated by Ulcerative Colitis

K. Matsuura, H. Kataoka, I. Naitoh, 2022, Internal medicine.

Complex structural variations in non-human primate hepatitis B virus

K. Matsuura, Etsuko Iio, Yasuhito Tanaka, 2021, Virology journal.

Long‐term outcomes of nasogastric tube with Gastrografin for adhesive small bowel obstruction

S. Ono, H. Nishie, Yasuyuki Okamoto, 2021, Journal of gastroenterology and hepatology.

The first management using intubation of a nasogastric tube with Gastrografin enterography or long tube for non-strangulated acute small bowel obstruction: a multicenter, randomized controlled trial

S. Takiguchi, M. Sugiura, S. Ono, 2020, Journal of Gastroenterology.

Novel Genetic Rearrangements Termed “Structural Variation Polymorphisms“ Contribute to the Genetic Diversity of Orthohepadnaviruses

K. Matsuura, Etsuko Iio, H. Kataoka, 2019, Viruses.

Serum angiopoietin‐2 levels predict regression of Mac‐2 binding protein glycosylation isomer‐based liver fibrosis after hepatitis C virus eradication by direct‐acting antiviral agents

K. Matsuura, H. Kataoka, S. Nojiri, 2022, Hepatology research : the official journal of the Japan Society of Hepatology.

Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation

K. Matsuura, H. Kataoka, S. Kusumoto, 2022, Hepatology research : the official journal of the Japan Society of Hepatology.

The neutrophil‐to‐lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis

K. Matsuura, H. Kataoka, S. Nojiri, 2023, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy of minocycline hydrochloride aspiration sclerotherapy with additional monoethanolamine oleate aspiration sclerotherapy for symptomatic hepatic cysts

K. Matsuura, H. Kataoka, Yoshinori Mori, 2022, Hepatology research : the official journal of the Japan Society of Hepatology.

Serum Angiopoietin-2 Levels Predict the Development of Hepatocellular Carcinoma following Hepatitis C Virus Eradication Using Direct-Acting Antiviral Agents

K. Matsuura, Etsuko Iio, Katsuya Nagaoka, 2024, Oncology.

MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents.

K. Matsuura, Etsuko Iio, Katsuya Nagaoka, 2024, Journal of gastroenterology.

Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysis

K. Matsuura, S. Nojiri, Yuta Suzuki, 2023, Cancer medicine.

Prognostic nutritional index after introduction of atezolizumab with bevacizumab predicts prognosis in advanced hepatocellular carcinoma: A multicenter study.

K. Matsuura, S. Nojiri, Yuta Suzuki, 2024, Oncology.